Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204698 · ClinicalTrials.gov registry record · Phase 2
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00204698 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 24 participants.
The verdict
NCT00204698, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study proposes to investigate prospectively, the presence of molecular markers for inflammation in laryngopharyngeal reflux (LPR) patients and to study the effect of a proton pump inhibitor (Aciphex) on these molecular markers. The investigators will be evaluating a group of patients before and after treatment. This group will be patients that have untreated laryngopharyngeal reflux diagnosed by laryngoscopic assessment and a 24-hour probe.
Interventions
- DRUG Aciphex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-08 |
| Est. Completion | 2006-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204698
The ClinicalTrials.gov registry entry for NCT00204698 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aciphex is the first listed.
NCT00204698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00204698 about?
NCT00204698 is a clinical study titled "Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment". This study proposes to investigate prospectively, the presence of molecular markers for inflammation in laryngopharyngeal reflux (LPR) patients and to study the effect of a proton pump inhibitor (Aciphex) on these molecular markers. The investigators will be evaluating a group of patients before an...
What is the current status of trial NCT00204698?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2003-08. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00204698?
The interventions under investigation include: Aciphex (DRUG).
Who is sponsoring clinical trial NCT00204698?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.